Crizotinib for the treatment of non-small-cell lung cancer-Reference-Cited by-同舟云学术

Crizotinib for the treatment of non-small-cell lung cancer

Published:2013-06-01 Issue:11 Volume:70 Page:943-947
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Timm Andrew¹,Kolesar Jill M.²

Affiliation:

1. School of Pharmacy, University of Wisconsin (UW)—Madison

2. School of Pharmacy, UW—Madison, and Director, 3P Analytical Instrumentation Laboratory, UW Carbone Comprehensive Cancer Center

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/70/11/943/28456281/ajhp0943.pdf

Reference26 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin.,2012

2. American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol.,2009

3. National Comprehensive Cancer Network. NCCN guidelines v2.2013 NSCLC [registration required]. www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (accessed 2013 Apr 1).

4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature.,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches;Biomedicines;2024-09-04

2. Using network pharmacology to discover potential drugs for hypertrophic scars;British Journal of Dermatology;2024-05-31

3. Crizotinib inhibits the metabolism of tramadol by non-competitive suppressing the activities of CYP2D1 and CYP3A2;PeerJ;2024-05-30

4. Research on Joint Drug Prediction Based on Bipartite Networks;Proceedings of the 2024 4th International Conference on Bioinformatics and Intelligent Computing;2024-01-26

5. Control of the activity and enantioselectivity in biocatalyzed procedures: immobilization, medium engineering, and protein engineering;Biocatalysis in Asymmetric Synthesis;2024